Molecular and Cellular Mechanisms of Lysosomal Storage Diseases

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-11-30

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The lysosome is a specialized part of the cell that functions to degrade metabolic wastes in the cell. Defects in the functioning of the lysosome result in accumulation and subsequent storage of such metabolic wastes. These defects lead to conditions known as lysosomal storage diseases (LSD). LSDs are caused by inherited genetic mutations and there are over 40 genetically distinct lysosomal storage diseases. Within each specific lysosomal storage disease there are variances in severity of disease, age of onset, and clinical presentation. Though the genetic mutations contributing to the disease have been largely clarified, the molecular and cellular mechanisms that contribute to variations in each distinct LSD remain unclear. With this study we intend to better understand at the cellular and molecular level how the accumulation and storage of metabolic wastes in the lysosome affect the clinical manifestation of LSDs, to detect changes in these mechanisms upon treatment administration, and to correlate these results to genetic information. The knowledge obtained from this research study could lead to better ways to diagnose and treat lysosomal storage diseases.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Genetic Studies of Lysosomal Storage Disorders

NCT00001215

Lysosomal Storage Disorders Gaucher Disease Parkinson Disease

ENROLLING_BY_INVITATION

Study of Glycogen Storage Disease and Associated Disorders

NCT00001342

Glycogen Storage Disease

COMPLETED

Exome Sequencing in Autistic Spectrum Disorder

NCT01059201

Autism Spectrum Disorder Autism Autistic Disorder

COMPLETED

Tissue Sample Study for Mitochondrial Disorders

NCT01803906

Mitochondrial Disorders Mitochondrial Disease Melas +6 more

ENROLLING_BY_INVITATION

Study of Inborn Errors of Cholesterol Synthesis and Related Disorders

NCT00046202

Lysosomal Storage Disease Cholesterol Metabolism

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lysosomal Storage Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject is greater than or equal to 1 day of age and less than or equal to 100 years of age
* Signed Informed Consent/Assent
* Subject is able and willing to comply with study protocol requirements.
* From clinical or blood laboratory findings subject has evidence of a lysosomal storage disease or a family member of a patient with lysosomal storage disease